NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

Formulary Update (June 2017)

Posted: June 26, 2017.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Alogliptin: DPP-4 Inhibitor of Choice

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

The position of alogliptin in the NHSGGC Formulary has changed.  The previous prescribing restriction limiting use in dual therapy has been remov...

Read More...

Fast acting insulin aspart

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

Fast acting Insulin aspart (Fiasp®) has been accepted by the SMC and added to the Formulary. It is a modified formulation of insulin aspart with the property of more rapid absorption of insulin from subcutaneous injection site than standard...

Read More...

Tiotropium: Braltus Zonda

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Respiratory

In April 2017, the ADTC accepted the Respiratory MCN’s recommendation on tiotropium inhaler devices. Braltus® Zonda Inhaler is now the preferred brand of tiotropium inhaler. Spiriva Respimat® remains a Total Formulary option. ...

Read More...

Butec (buprenorphine) patch

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Opioids

Butec® is the NHSGGC preferred brand of buprenorphine 7 day transdermal patch across primary and secondary care. It is restricted to specialist use only in elderly patients (over 65 years) where standard analgesic options are ineffective or...

Read More...

Medicines Update Oncology June 2017

Posted: June 21, 2017.
Category - Medicines Update Oncology

NEW: Guideline for the Management of Immune-related Adverse Events The West of Scotland Cancer Network (WOSCaN) Guidelines for Management of Immune-related Adverse Events have recently been issued by the West of Scotland Cancer Network ...

Read More...

Medicines Update Primary Care June 2017

Posted: June 14, 2017.
Category - Medicines Update Primary Care
Tagged with - Diabetes NSAIDs The Scottish Therapeutics Utility (STU) EFIPPS Study

To view this bulletin in PDF format please click here 

This bulletin contains informtion on:

  • The Scottish Therapeutics Utility (STU) and the Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) Study
  • Pharmacist Independent Prescribers and Electronic Prescribing    
  • Hypoglycaemia Treatment with Sugary Drinks             

Read More...

Adult Therapeutics Handbook: Content update June 2017

Posted: June 09, 2017.
Category - Medicines Update Acute

The Therapeutics Handbook content has been updated and includes the following main change: Cardiovascular System section: Guidelines within the cardiova...

Read More...

Guideline News May 2017

Posted: May 30, 2017.
Category - Medicines Update Acute

Guideline News May 2017 

Read More...

GGC Lipid Guideline Update

Posted: May 26, 2017.
Category - Medicines Update

This blog summarises the main changes of the cholesterol guidelines updated in 2017

Read More...